Perineal Massage in Women With Gynecological Cancer
Oncological Perineal Massage in Vaginal Stenosis and Dyspareunia in Women With Gynecological Cancer
1 other identifier
interventional
35
1 country
1
Brief Summary
The high incidence of gynecological cancers, together with dyspareunia and vaginal stenosis, some of its most frequent sequelae, create the need to continue studying and researching oncological physiotherapy techniques that treat and prevent these sequelae, in order to preserve and/or improve the quality of life of cancer patients. Therefore, through this study, we sought to verify the effectiveness of oncological perineal massage to treat pain during sexual intercourse and vaginal stenosis. The objective of this study will be to demonstrate the effectiveness of a treatment that will consist of a health education session related to the pelvic floor and the consequences related to cancer along with ten sessions of oncological perineal massage that will be carried out for fifty minutes, once a week.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2024
CompletedFirst Posted
Study publicly available on registry
May 29, 2024
CompletedStudy Start
First participant enrolled
May 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2025
CompletedMay 1, 2026
April 1, 2026
1.6 years
May 22, 2024
April 27, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Pain (Visual Analoge Scale)
Visual Analogical Scale (VAS) is a unidimensional measure of pain intensity, used to record patients' pain progression, or compare pain severity between patients with similar conditions. VAS is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured orientated from the left "0" (worst) to the right "10"(best)
Change from baseline at six months
Secondary Outcomes (4)
Criteria for Adverse Events (CTCAE)
Change from baseline at six months
Quality of life (EORCT QLQ-C30)
Change from baseline at six months
Female sexual function index
Change from baseline at six months
Likert questionnaire by sexual dysfunction
Change from baseline at six months
Study Arms (2)
Perineal massage
EXPERIMENTALTen sessions of perineal massage, which will be carried out for fifty minutes, once a week, together with a health education program.
Treatment with dilators
ACTIVE COMPARATORA health education session will be held but then the use of vaginal dilators will be done according to the gold standard treatment.
Interventions
The technique will be applied for approximately twenty minutes and will be carried out as follows: the vaginal dilator is introduced progressively using crescent-shaped movements. Once the dilator is fully inserted, movements will be made from bottom to top and from one side to the other, and then continue with the crescent-shaped movements.
The treatment will consist of the use of vaginal dilators according to the gold standard proposed in the literature. It will consist of introducing the same dilators as for the experimental group, with the same time schedule, but without massage, only introducing the dilator and keeping it in the vagina for 20 minutes.
Eligibility Criteria
You may qualify if:
- Women between 18 and 52 years old
- Oncology patients with a diagnosis of dyspareunia and vaginal stenosis related to treatments.
- Patients with QT/RT/BT treatment who have a diagnosis of dyspareunia and vaginal stenosis.
- Patients on hormonal suppressive treatment with a diagnosis of dyspareunia and vaginal stenosis.
You may not qualify if:
- Patients who do not accept intracavitary treatment.
- Patients with abdominopelvic surgical treatment prior to oncological process.
- Patients with a diagnosis of dyspareunia prior to cancer.
- Patients with vaginal narrowing prior to cancer.
- Patients with menopause at the time of cancer diagnosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Asociación Española Contra el Cáncer en la provincia de Santa cruz de Tenerife.
Santa Cruz de Tenerife, Tenerife, Spain
Related Publications (1)
Perez-Garcia R, Abuin-Porras V, Minguez-Esteban I, Pecos-Martin D. Oncological perineal massage in vaginal stenosis and dyspareunia in women with gynecological cancer: a randomized controlled trial. Front Oncol. 2025 Nov 28;15:1680126. doi: 10.3389/fonc.2025.1680126. eCollection 2025.
PMID: 41395600DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raquel Perez-García
Asociación Española Contra el Cáncer en la provincia de Santa cruz de Tenerife.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 22, 2024
First Posted
May 29, 2024
Study Start
May 31, 2024
Primary Completion
December 20, 2025
Study Completion
December 20, 2025
Last Updated
May 1, 2026
Record last verified: 2026-04